Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction.
Am. Heart J., Oct;126(4):819-26 (1993)
Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group.
Circulation., Jul;90(1):114-20 (1994)
Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention.
Am. Heart J., Apr;145(4):708-15 (2003)
The failure of years of experience with electrocardiographic transmission from paramedics to the hospital emergency department to reduce the delay from door to primary coronary intervention below the 90-minute threshold during acute myocardial infarction.
J Electrocardiol., Apr;39(2):136-41 (2006)
Subxiphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy.
Chest., Apr;101(4):938-43 (1992)
A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention.
Am. J. Cardiol., Apr;81(8):970-6 (1998)
Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction.
J. Am. Coll. Cardiol., Nov;32(5):1312-9 (1998)
Etiology of large pericardial effusions.
Am. J. Med., Aug;95(2):209-13 (1993)
Mycoplasmal pericarditis: evidence of invasive disease.
Clin. Infect. Dis., Aug;17 Suppl 1:S58-62 (1993)
A prospective trial of subxiphoid pericardiotomy in the diagnosis and treatment of large pericardial effusion. A follow-up report.
Ann. Surg., Dec;218(6):777-82 (1993)
Cytomegalovirus pericarditis: a case series and review of the literature.
Am. J. Med. Sci., Apr;309(4):229-34 (1995)
Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7.
Circulation., Sep;96(6):1776-82 (1997)
Diagnosis and management (by subxiphoid pericardiotomy) of large pericardial effusions causing cardiac tamponade.
Am. J. Cardiol., Apr;69(12):1075-8 (1992)
Experience with the use of tPA in the treatment of acute myocardial infarction.
Ann Emerg Med., Nov;17(11):1176-89 (1988)
Administration of thrombolytic therapy in the community hospital: established principles and unresolved issues.
J. Am. Coll. Cardiol., Dec;12(6 Suppl A):32A-43A (1988)
Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study.
Am. J. Cardiol., Feb;63(7):423-8 (1989)
Gonococcal endocarditis: a new look at an old disease.
Medicine (Baltimore)., Nov;68(6):375-80 (1989)
Results of high dose intravenous urokinase for acute myocardial infarction.
Am. J. Cardiol., Jan;65(3):124-31 (1990)
Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage. The TAMI Study Group.
Am. J. Cardiol., Dec;66(20):1418-21 (1990)
From HIRMIT to the Cape May Lighthouse. Revascularization reconsidered in very high risk patients at the Duke Heart Center.
N C Med J., Dec;52(12):618-20 (1991)
Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group.
J. Am. Coll. Cardiol., Mar;19(3):482-9 (1992)
Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy. The TAMI Study Group.
J. Am. Coll. Cardiol., Mar;21(3):597-603 (1993)